Pulmonary Hypertension
The Scottish Pulmonary Vascular Unit based between the Gartnavel General, Glasgow and the Golden Jubilee National Hospital, offers diagnosis, specialised treatment and long-term follow-up for patients with pulmonary arterial hypertension (PAH). The service also works closely with the nationally-designated services for adults and children with congenital heart disease to offer advice in the treatment of PAH associated with congenital heart disease.
PAH is a rare lung disorder in which the blood pressure in the pulmonary artery rises far above normal levels. At the same time as the pressure rises, the walls of the blood vessels (pulmonary arteries) become thicker. Without treatment, life expectancy in advanced disease is less than 2 years. There are formal international Diagnostic Definitions for Pulmonary Hypertension which relates to specific diseases that PAH commonly occurs. There are effective medical therapies that improve the quality of life and life expectancy.
Annual Report
The most recent annual report for the service is available below:
Scottish Pulmonary Vascular Unit Annual Report 2009/10 [7 pages, 152Kb]
Lead clinician:
Professor Andrew Peacock, Consultant Respiratory Physician
Service contact address:
Golden Jubilee National Hospital
Beardmore Street
Clydebank
West Dunbartonshire
G81 4HX
National Services Division contacts:
To contact members of NSD staff, please visit our staff contacts page.
James Steven, Programme Manager
Louise Wilson, Assistant Programme Manager
Jean Travers, Programme Support Officer
